Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment
Recommendations
Case detection
Case confirmation
Subtype classification
Treatment
In addition, if BP fails to normalize with glucocorticoid alone, an MR antagonist may be added. For children, the glucocorticoid dosage should be adjusted for age and body weight, and BP targets should be determined from age- and gender-specific published normative data.
Recommendation Grading
Overview
Title
Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment
Authoring Organization
Endocrine Society
Endorsing Organizations
American Association of Endocrine Surgeons
American Heart Association
Publication Month/Year
May 1, 2016
Last Updated Month/Year
March 26, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
To develop clinical practice guidelines for the management of patients with primary aldosteronism.
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Older adult
Health Care Settings
Ambulatory
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Diagnosis, Assessment and screening, Treatment, Management
Diseases/Conditions (MeSH)
D000450 - Aldosterone
Keywords
primary aldosteronism, PA
Source Citation
John W. Funder, Robert M. Carey, Franco Mantero, M. Hassan Murad, Martin Reincke, Hirotaka Shibata, Michael Stowasser, William F. Young, Jr, The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Volume 101, Issue 5, 1 May 2016, Pages 1889–1916, https://doi.org/10.1210/jc.2015-4061